Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

KYTHERA Biopharmaceuticals Inc (NASDAQ:KYTH)

74.52
Delayed Data
As of Jul 31
 +0.04 / +0.05%
Today’s Change
29.86
Today|||52-Week Range
76.31
+114.88%
Year-to-Date

Today’s Trading

Previous close74.48
Today’s open74.52
Day’s range74.33 - 74.54
Volume613,511
Average volume (3 months)932,658
Market cap$1.9B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-122.88%
Earnings growth (this year)-23.21%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book28.43

Competitors

 Today’s
change
Today’s
% change
OCIPOCI Partners LP0.000.00%
PPOPolypore Internation...-0.05-0.08%
CCMPCabot Microelectroni...-0.62-1.35%
EVGNEvogene Ltd+0.01+0.11%
Data as of 4:03pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$1.19
Annual revenue (last year)$0.00
Annual profit (last year)-$135.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Keith R. Leonard
Vice President-
Operations
Douglas A. Rich
Corporate headquarters
Westlake, California

Forecasts